Burns J, Jean-Pierre P (2018) Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature. Cardiol Res Pract 2018:1–6

Article  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol 76(25):e159–240

Article  PubMed  Google Scholar 

Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J

Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 379(7):655–668

Article  PubMed  Google Scholar 

Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A et al (2022) Recommendations for Multimodality Cardiovascular Imaging of Patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 35(6):533–569

Article  PubMed  Google Scholar 

Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA et al (2022) Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review. Journal of the American College of Cardiology, vol 79. Elsevier Inc., pp 372–389

Rowin EJ, Maron BJ, Maron MS (2020) The hypertrophic cardiomyopathy phenotype viewed through the prism of Multimodality Imaging: clinical and etiologic implications. Vol. 13, JACC: Cardiovascular Imaging. Elsevier Inc., pp 2002–2016

Bagnall RD, Ingles J, Dinger ME, Cowley MJ, Ross SB, Minoche AE et al (2018) Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 72(4):419–429

Article  PubMed  Google Scholar 

Teekakirikul P, Zhu W, Huang HC, Fung E (2019) Hypertrophic cardiomyopathy: an overview of Genetics and Management. Biomolecules 9(12):878

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG (2016) The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy A Test in Context

Maron BJ, Maron MS, Maron BA, Loscalzo J (2019) Moving beyond the Sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC Review topic of the Week. Journal of the American College of Cardiology, vol 73. Elsevier USA, pp 1978–1986

Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM et al (2024) 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol 83(23):2324–2405

Article  PubMed  Google Scholar 

Hindieh W, Chan R, Rakowski H (2017) Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy. Vol. 19, Current Cardiology Reports. Current Medicine Group LLC 1

Liu J, Tan T, Wei P, Ma J, Zhong L, Qiu H et al (2023) Anomalous papillary muscle insertion into the mitral valve leaflet in hypertrophic obstructive cardiomyopathy: a lip nevus sign in echocardiography. Front Cardiovasc Med. ;10

Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M et al (2015) Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy: Implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography. Circ Cardiovasc Imaging. ;8(7)

Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR et al (2011) Mitral valve abnormalities identified by Cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 124(1):40–47

Article  CAS  PubMed  Google Scholar 

Verheyen N, Batzner A, Zach D, Zirlik A, Gerull B, Frantz S et al (2023) Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 24(6):710–718

Article  PubMed  PubMed Central  Google Scholar 

Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P et al (2007) Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart 94(10):1295–1301

Article  PubMed  Google Scholar 

Nara I, Iino T, Watanabe H, Sato W, Watanabe K, Shimbo M et al (2018) Morphological determinants of obstructive hypertrophic cardiomyopathy obtained using echocardiography. Int Heart J 59(2):339–346

Article  PubMed  Google Scholar 

Oktay V, Arslan S, Gecit MH, Bulat Z, Gokce ME (2024) Short- and mid-term outcomes of early alcohol septal ablation therapy for patients with mildly symptomatic hypertrophic obstructive cardiomyopathy: a Tertiary Center Experience. J Clin Med 13(5):1444

Article  PubMed  PubMed Central  Google Scholar 

Kwon DH, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY (2010) Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg 140(2):317–324

Article  PubMed  Google Scholar 

Nakamori S, Ngo LH, Tugal D, Manning WJ, Nezafat R (2018) Incremental value of Left Atrial Geometric Remodeling in Predicting Late Atrial Fibrillation recurrence after pulmonary vein isolation: a Cardiovascular magnetic resonance study. J Am Heart Assoc 7:19

Article  Google Scholar 

Muresan ID, Zlibut A, Orzan RI, Agoston R, Cojan-Minzat BO, Grosu AI et al (2022) Characterization of left atrial geometry and function in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study. Eur Rev Med Pharmacol Sci 26(12):4318–4330

CAS  PubMed  Google Scholar 

Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Yu-An Ding P et al (2001) Noninvasive single-beat determination of left ventricular end-systolic elastance in humans, vol 38. Journal of the American College of Cardiology

Ikonomidis I, Aboyans V, Blacher J, Brodmann M, Brutsaert DL, Chirinos JA et al (2019) The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail 21(4):402–424

Article  PubMed  Google Scholar 

Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB et al (2015) Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Sci 17(11):880–888

Google Scholar 

Hathaway J, Heliö K, Saarinen I, Tallila J, Seppälä EH, Tuupanen S et al (2021) Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients. BMC Cardiovasc Disord. ;21(1)

Oktay V, Tüfekçioğlu O, Yılmaz DÇ, Onrat E, Karabulut D, Çelik M et al (2023) The definition of Sarcomeric and non-sarcomeric gene mutations in hypertrophic cardiomyopathy patients: a Multicenter Diagnostic Study Across Türkiye. Anatol J Cardiol 27(11):628–638

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P et al (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial diseases. Eur Heart J 31(22):2715–2726

Article  PubMed  Google Scholar 

Rosmini S, Biagini E, O’Mahony C, Bulluck H, Ruozi N, Lopes LR et al (2017) Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy. Heart 103(4):300–306

Article  PubMed  Google Scholar 

Captur G, Lopes LR, Mohun TJ, Patel V, Li C, Bassett P et al (2014) Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7(6):863–871

Article  PubMed  PubMed Central  Google Scholar 

Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E et al (2017) Lack of phenotypic differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin heavy Chain)- Versus MYBPC3 (myosin-Binding protein C)-Related hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. ;10(2)

Seidman JG, Seidman C (2001) The Genetic Basis for Cardiomyopathy: Review from Mutation Identification to Mechanistic Paradigms. Vol. 104, Cell

Maurizi N, Michels M, Rowin EJ, Semsarian C, Girolami F, Tomberli B et al (2019) Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy. Circulation 139(6):830–833

Article  PubMed  Google Scholar